IP Library Granted Patent US 9,855,387
Granted Patent B2
US 9,855,387 · App. 13/988,800 · Granted Jan 2, 2018

Medical fluid injector system

Inventors: James R. Small (Beavercreek, OH); Jeffrey A. Perkins (Mainville, OH); Frank M. Fago (Mason, OH); Mark Jon Glenn (Phoenix, AZ)
Assignee: LIEBEL-FLARSHEIM COMPANY LLC
A61M5/2066A61M5/1407A61M5/14546A61M5/16827A61B6/548A61M2205/502
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,855,387
App. No.
13/988,800
Granted
Jan 2, 2018
Kind
B2
Abstract

A medical fluid injector system ( 450 ) is disclosed that may utilize one or more of flow rate determination logic ( 130 ), injection volume determination logic ( 132 ), display control logic ( 134 ), drive ram motion control logic ( 136 ), and pressure monitoring logic ( 138 ). The flow rate determination logic ( 130 ), injection volume determination logic ( 132 ), and display control logic ( 134 ) each may utilize a concentration input ( 172, 192, 202 ) to calculate flow rates, injection volumes, and generate multi-color graphics, respectively, for a simultaneous injection configuration. The drive ram motion control logic ( 136 ) may utilize both a target pressure and a monitored pressure to derive a velocity for advancing a drive ram. The pressure monitoring logic ( 138 ) may provide a monitored pressure value for the drive ram control logic ( 136 ), where this monitored pressure value may be derived from the input power being used to advance a drive ram and the drive ram velocity.

Claims (26)

1. A medical fluid injector system comprising:

a syringe plunger driver comprising a drive source and a drive ram, wherein said drive source is operable to advance said drive ram in a fluid discharge direction to cause a discharge of a medical fluid from a syringe when incorporated by said medical fluid injector system; and

drive ram motion control logic configured to derive a drive ram velocity increase from a target pressure by deriving at least one drive ram velocity increase value, wherein said target pressure is associated with advancement of said drive ram in said fluid discharge direction, and wherein said target pressure is a single value throughout a first time range;

wherein said drive ram motion control logic is configured to incrementally increase a drive ram velocity in view of said at least one drive ram velocity increase value during execution of a current phase of an injection protocol until an occurrence of a first condition, after which said drive ram motion control logic is configured to maintain said drive ram velocity at a value associated with satisfaction of said first condition for a continued execution of said current phase of said injection protocol;

wherein said first condition is satisfied by said medical fluid injector system reaching said target pressure during said current phase of said injection protocol without necessarily reaching a target flow rate for said current phase, and wherein said first condition is also satisfied by said medical fluid injector system reaching said target flow rate without necessarily reaching said target pressure.

2. The medical fluid injector system of claim 1 , wherein said target flow rate comprises user input.

3. The medical fluid injector system of claim 1 , wherein said drive ram motion control logic incrementally increases said drive ram velocity in view of said at least one drive ram velocity increase value throughout said first time range, wherein said first time range extends from a beginning of an associated phase of said injection protocol and until any occurrence of said first condition.

4. The medical fluid injector system of claim 1 , wherein said target pressure comprises an independent variable, and wherein said at least one drive ram velocity increase value comprises a dependent variable.

5. The medical fluid injector system of claim 1 , wherein said drive ram motion control logic is configured to repeatedly derive said at least one drive ram velocity increase value from said target pressure.

6. The medical fluid injector system of claim 5 , wherein said drive ram motion control logic is configured to repeatedly derive said at least one drive ram velocity increase value from both said target pressure and a monitored pressure.

7. The medical fluid injector system of claim 6 , wherein said drive ram motion control is configured to repeatedly derive said at least one drive ram velocity increase value from a differential between said target pressure and said monitored pressure.

8. The medical fluid injector system of claim 6 , wherein said drive ram motion control logic is configured to repeatedly derive said at least one drive ram velocity increase value to reduce an error between said target pressure and said monitored pressure.

9. The medical fluid injector system of claim 6 , wherein said drive ram motion control logic utilizes at least a two-term controller.

10. The medical fluid injector system of claim 9 , wherein a proportional term and a derivative term are used by said controller.

11. The medical fluid injector system of claim 6 , wherein said drive ram motion control logic utilizes a proportional-integral-derivative controller.

12. The medical fluid injector system of claim 1 , wherein said drive ram motion control logic is configured to recursively derive said at least one drive ram velocity increase value from said target pressure.

13. The medical fluid injector system of claim 1 , wherein said drive ram motion control logic is configured to iteratively derive said at least one drive ram velocity increase value from said target pressure.

14. The medical fluid injector system of claim 1 , wherein said drive ram motion control logic is configured to derive said at least one drive ram velocity increase value both from said target pressure and a monitored pressure.

15. The medical fluid injector system of claim 14 , wherein said drive ram motion control logic is configured to derive said drive ram velocity increase from a differential between said target pressure and said monitored pressure.

16. The medical fluid injector system of claim 14 , wherein said drive ram motion control logic utilizes at least a two-term controller.

17. The medical fluid injector system of claim 16 , wherein a proportional term and a derivative term are used by said controller.

18. The medical fluid injector system of claim 14 , wherein said drive ram motion control logic utilizes a proportional-integral-derivative controller.

19. The medical fluid injector system of claim 1 , wherein said target pressure is set in response to user input.

20. The medical fluid injector system of claim 1 , wherein said target pressure comprises user input.

21. The medical fluid injector system of claim 1 , wherein said first time range is an entirety of said current phase of said injection protocol.

22. The medical fluid injector system of claim 21 , wherein said first time range is an entirety of said current phase and each of one or more additional phases of said injection protocol.

Assignments (5)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
RELEASE OF SECURITY INTEREST Recorded Nov 30, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 037172/0094 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2014
From: MALLINCKRODT LLC
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 034715/0531 →
SECURITY INTEREST Recorded Mar 19, 2014
From: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS INC.; MALLINCKRODT CARIBBEAN, INC.; MALLINCKRODT US POOL LLC; MALLINCKRODT INC.; LUDLOW CORPORATION; CNS THERAPEUTICS, INC.; ENTERPRISES HOLDINGS, INC.; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS, INC; MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC; MALLINCKRODT ENTERPRISES HOLDINGS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 032480/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2013
From: SMALL, JAMES R.; PERKINS, JEFFREY A.; FAGO, FRANK M.; GLENN, MARK JON
To: MALLINCKRODT LLC
Reel/Frame 030465/0222 →
Continuity (2)
Provisional Application 61417091 · Nov 24, 2010
Related Publication 20130245439A1 · Sep 19, 2013